Arkolith/Insider Trading/PNT/Form 4

McCann Joe A.

Chief Executive Officer, DirectorPOINT Biopharma Global Inc. (PNT) · full profile →Form 4 · filed Dec 27, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 22, 2023Tender(U)2K——0
Dec 22, 2023Tender(U)3.5M——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 27, 2023Disposed to issuer(D)693K——0
Dec 27, 2023Disposed to issuer(D)382K——0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-129775) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML